Allosteric hotspots in the main protease of SARS-CoV-2
Léonie StrömichiD, Nan WuiD, Mauricio BarahonaiD, Sophia N. YalirakiiD
Abstract
AO_SCPLOWBSTRACTC_SCPLOWInhibiting the main protease of SARS-CoV-2 is of great interest in tackling the COVID-19 pandemic caused by the virus. Most efforts have been centred on inhibiting the binding site of the enzyme. However, considering allosteric sites, distant from the active or orthosteric site, broadens the search space for drug candidates and confers the advantages of allosteric drug targeting. Here, we report the allosteric communication pathways in the main protease dimer by using two novel fully atomistic graph theoretical methods: Bond-to-bond propensity analysis, which has been previously successful in identifying allosteric sites without a priori knowledge in benchmark data sets, and, Markov transient analysis, which has previously aided in finding novel drug targets in catalytic protein families. We further score the highest ranking sites against random sites in similar distances through statistical bootstrapping and identify four statistically significant putative allosteric sites as good candidates for alternative drug targeting.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 23
- FWCI
- 2.43
- Field percentile
- top 10%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibition of SARS-CoV-2 main protease by allosteric drug-binding
S. Guenther, P. Y. A. Reinke, … Schwi·bioRxiv·Nov 12, 2020
- Identification of Novel Allosteric Sites of SARS-CoV-2 Papain-Like Protease (PLpro) for the Development of COVID-19 Antivirals
J. C. Ferreira, K. Al Adem, … W. M. Rabeh·bioRxiv·May 16, 2023
- Computational Analysis of Dynamic Allostery and Control in the SARS-CoV-2 Main Protease
I. Dubanevics, T. C. McLeish·bioRxiv·May 21, 2020
- Allosteric inhibition of the SARS-CoV-2 main protease - insights from mass spectrometry-based assays
T. J. El-Baba, C. A. Lutomski, … C. V. Robinson·bioRxiv·Jul 29, 2020
- Identification of C270 as a novel site for allosteric modulators of SARS-CoV-2 papain-like protease
Hangchen Hu, Qian Wang, … Yechun Xu·bioRxiv·Mar 30, 2022
- Elucidation of cryptic and allosteric pockets within the SARS-CoV-2 protease
T. Sztain, R. E. Amaro, J. A. McCammon·Journal of Chemical Information and ModelingPeer-reviewed·Jul 26, 2021